IL-21 is a central memory T cell-associated cytokine that inhibits the generation of pathogenic Th1/17 effector cells

Journal of Immunology

Volumn 193, Issue 7, 2014, Pages 3322-3331

  Kastirr, Ilko ^a,b,c   Maglie, Stefano ^a   Paroni, Moira ^a   Alfen, Johanna Sophie ^a   Nizzoli, Giulia ^a   Sugliano, Elisa ^a   Crosti, Maria Cristina ^a   Moro, Monica ^a   Steckel, Bodo ^b,c   Steinfelder, Svenja ^b,c   Stölzel, Katharina ^c   Romagnani, Chiara ^b   Botti, Fiorenzo ^d,e   Caprioli, Flavio ^e,f   Pagani, Massimilliano ^a   Abrignani, Sergio ^a   Geginat, Jens ^a  

^a Istituto Nazionale di Genetica Molecolare   (Italy)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF MILAN   (Italy)

^e Unita Operativa di Chir Generale   (Italy)

^f FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 21; INTERLEUKIN 6; TRANSCRIPTION FACTOR T BET; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RORC PROTEIN, HUMAN; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE RELEASE; EFFECTOR CELL; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; ANIMAL; AUTOIMMUNE DISEASE; CELL DIFFERENTIATION; CLINICAL TRIAL; FEMALE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MALE; MOUSE; PATHOLOGY; UPREGULATION;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; FEMALE; HUMANS; IMMUNOLOGIC MEMORY; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-6; INTERLEUKINS; MALE; MICE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; T-BOX DOMAIN PROTEINS; TH1 CELLS; TH17 CELLS; UP-REGULATION;

EID: 84907210923     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1400775     Document Type: Article

References (71)

1. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
2. Romagnani, S. 1991. Human TH1 and TH2 subsets: doubt no more. Immunol. Today 12: 256-257.
3. Manetti, R., F. Gerosa, M. G. Giudizi, R. B iagiotti, P. Parronchi, M. P. Piccinni, S. Sampognaro, E. Maggi, S. Romagnani, G. Trinchieri, et al. 1994. Interleukin 12 induces stable priming for interferon gamma (IFN-gamma) production during differentiation of hum an T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J. Exp. Med. 179: 1273-1283.
4. Szabo, S. J., S. T. Kim, G. L. Costa, X. Zhang, C. G. Fathman, and L. H. Glimcher. 2000. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
5. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
6. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
7. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of inte rleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
8. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454: 350-352.
9. Volpe, E., N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupé, E. Barillot, and V. Soumelis. 2008. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat. Immunol. 9: 650-657.
10. Wilson, N. J. , K. Boniface, J. R. Chan, B. S. McKenzie, W. M. Blumenschein, J. D. Mattson, B. Basham, K. Smith, T. Chen, F. Morel, et al. 2007. Development, cytokine profile and function of human interleukin 17-producin g helper T cells. Nat. Immunol. 8: 950-957.
11. Cosmi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008 . Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205: 1903-1916.
12. El-Behi, M., B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G. X. Zhang, B. N. Dittel, and A. Rostami. 2011. The encephalitogenicity of T(H)17 cells is dependent on IL-1-and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12: 568-575.
13. Coccia, M., O. J. Ha rrison, C. Schiering, M. J. Asquith, B. Becher, F. Powrie, and K. J. Maloy. 2012. IL-1b mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4(+) Th17 cells. J. Exp. Med. 209: 1595-1609.
14. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397.
15. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
16. Codarri, L., G. Gy€ ulvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORgt drives production of the cytokine GM-CSF in helper T cells, whic h is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
17. Griseri, T., B. S. McKenzie, C. Schiering, and F. Powrie. 2012. Dysregulated hematopoietic stem a nd progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation. Immunity 37: 1116-1129.
18. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filì, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
19. Kebir, H., I. Ifergan, J. I. Alvarez, M. Bernard, J. Poirier, N. Arbour, P. Duquette, and A. Prat. 2009. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis. Ann. Neurol. 66: 390-402.
20. Abraham, C., and J. H. Cho. 2009. IL-23 and autoimmunity: new insights into the pathogenesis of inflammatory bowel disease. Annu. Rev. Med. 60: 97-110.
21. Sarin, R., X. Wu, and C. Abraham. 2011. Inflammatory disease protective R 381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc. Natl. Acad. Sci. USA 108: 9560-9565.
22. Safrany, E., and B. Melegh. 2009. Functional varian ts of the interleukin-23 receptor gene in non-gastrointestinal autoimmune diseases. Curr. Med. Chem. 16: 3766-3774.
23. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Dal y, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genomewide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463.
24. Zielinski, C. E., F. Mele, D. Aschenbrenner, D. Jarrossay, F. Ronchi, M. Gattorno, S. Monticelli, A. Lanzavecchia, and F. Sallusto. 2012. Pathogeninduced human TH17 cells produce IFN-g or IL-10 and are regulated by IL-1b. Nature 484: 514-518.
25. Kleinewietfeld M.,A. Manzel,J. Titze,H. Kvakan,N. Yosef,Linker R.A.,D.N. Muller,D.A. Hafler. 2013. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature.496: 518-522.
26. Fantini, M. C., G. Monteleone, and T. T. MacDonald. 2008. IL-21 comes of age as a regulator of effector T cells in the gut. Mucosal Immunol. 1: 110-115.
27. Spolski, R., H. P. Kim, W. Zhu, D. E. Levy, and W. J. Leonard. 2009. IL-21 mediates suppressive effects via its induction of IL-10. J. Immunol. 182: 2859-2867.
28. Pène, J., J. F. Gauchat, S. Lécart, E. Drouet, P. Guglielmi, V. Boulay, A. Delwail, D. Foster, J. C. Lecron, and H. Yssel. 2004. Cutting edge: IL-21 is a switch factor for the production of IgG1 and IgG3 by human B cell s. J. Immunol. 172: 5154-5157.
29. Ettinger, R., G. P. Sims, A. M. Fairhurst, R. Robbins, Y. S. da Silva, R. Spolski, W. J. Leonard, and P. E. Lipsky. 2005. IL-21 induces differentiati on of human naive and memory B cells into antibody-secreting plasma cells. J. Immunol. 175: 7867-7879.
30. Zeng, R., R. Spolski, S. E. Finkelstein, S. Oh, P. E. Kovanen, C. S. Hinrichs, C. A. Pise- Masison, M. F. Radonovich, J. N. Brady, N. P. Restifo, et al. 2005. Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and function. J. Exp. Med. 201: 139-148.
31. Cui, W., Y. Liu, J. S. Weinstein, J. Craft, and S. M. Kaech. 2011. An interleukin-21-interleukin-10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells. Immunity 35: 792-805.
32. Bryant, V. L ., C. S. Ma, D. T. Avery, Y. Li, K. L. Good, L. M. Corcoran, R. de Waal Malefyt, and S. G. Tangye. 2007. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicul ar helper cells. J. Immunol. 179: 8180-8190.
33. Elsaesser, H., K. Sauer, and D. G. Brooks. 2009. IL-21 is required to control chronic viral infection. Science 324: 1569-1572.
34. Frö hlich, A., J. Kisielow, I. Schmitz, S. Freigang, A. T. Shamshiev, J. Weber, B. J. Marsland, A. Oxenius, and M. Kopf. 2009. IL-21R on T cells is critical for sustained functionality and contro l of chronic viral infection. Science 324: 1576-1580.
35. Yi, J. S., M. Du, and A. J. Zajac. 2009. A vital role for interleukin-21 in the control of a chronic viral infection. Science 324: 1572-1576.
36. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs T(H)-17 cell differentiation by prom oting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974.
37. Caprioli, F., M. Sarra, R. Caruso, C. Stolfi, D. Fina, G. Sica, T. T. MacDonald, F. Pallone, and G . Monteleone. 2008. Autocrine regulation of IL-21 production in human T lymphocytes. J. Immunol. 180: 1800-1807.
38. Schmitt, N., R. Morita, L. Bourdery, S. E. Bentebibel, S. M. Zurawski, J. Banchereau, and H. Ueno. 2009. Human dendritic cells induce the differentiation of interleukin-21-producing T follicular helper-like cells through interleukin-12. Immunity 31: 158-169.
39. Ma, C. S., S. Suryani, D. T. Avery, A. Chan, R. Nanan, B. Santner-Nanan, E. K. Deenick, and S. G. Tangye. 2009. Early commitment of naive human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. I mmunol. Cell Biol. 87: 590-600.
40. Suto, A., D. Kashiwakuma, S. Kagami, K. Hirose, N. Watanabe, K. Yokote, Y. Saito, T. Nakayama, M. J. Grusby, I. Iwamoto, and H. Nakajima. 200 8. Development and characterization of IL-21-producing CD4+ T cells. J. Exp. Med. 205: 1369-1379.
41. Nurieva, R., X. O. Yang, G. Martinez, Y. Zhang, A. D. Panopoulos, L.Ma, K. Schluns, Q. Tian, S. S. Watowich, A. M. Jetten, and C. Dong. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448: 480-483.
42. Korn, T., E. Bettelli, W. Gao, A. Awasthi, A. Jäger, T. B. Strom, M. Oukka, and V. K. Kuchroo. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448: 484-487.
43. Hube r, M., A. Brüstle, K. Reinhard, A. Guralnik, G. Walter, A. Mahiny, E. von Löw, and M. Lohoff. 2008. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. A cad. Sci. USA 105: 20846-20851.
44. Kotlarz, D., N. Ziętara, G. Uzel, T. Weidemann, C. J. Braun, J. Diestelhorst, P. M. Krawitz, P. N. Robinson, J. Hecht, J. Puchałka, et al. 2013. Loss-offunction mutations in the IL-21 receptor gene cause a primary immunodeficiency syndrome. J. Exp. Med. 210: 433-443.
45. Dolff, S.,W. H. Abdulahad, J.Westra, B. Doornbos-van der Meer, P. C. Limburg, C. G. Kallenberg, and M. Bijl. 2011. Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus. Arthritis Res . Ther. 13: R157.
46. Herber D.,T. P. Brown,S. Liang,D. A. Young,M. Collins,K. Dunussi-Joannopoulos. 2007. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade w ith IL-21R.Fc reduces disease progression. J. Immunol. 178: 3822-3830.
47. Sutherland, A. P., T. Van Belle, A. L. Wurster, A. Suto, M. Michaud, D. Zhang, M. J. Grusby, and M. von Herrath. 2009. Interleukin-21 is required for the development of type 1 diabetes in NOD mice. Diabetes 58: 1144-1155.
48. McPhee, C. G., J. A. Bubier, T. J. Sproule, G. Park, M. P. Steinbuck, W. H. Schott, G. J. Christianson, H. C. Morse, 3rd, and D. C. Roopenian. 2013. IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice. J. Immunol. 191: 4581-4588.
49. Van Belle, T. L., S. Nierkens, R. Arens, and M. G. von Herrath. 2012. Interleukin-21 receptor-mediated signals control autoreactive T cell infiltration in pancreatic islets. Immunity 36: 1060-1072.
50. Sonderegger, I., J. Kisielow, R. Meier, C. King, and M. Kopf. 2008. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo. Eur. J. Immunol. 38: 1833-1838.
51. Coquet, J. M., S. Chakravarti, M. J. Smyth, and D. I. Godfrey. 2008. Cutting edge: IL-21 is not essential for Th17 differentiation or experimental autoimmune encephalomyelitis. J. Immunol. 180: 7097-7101.
52. Nizzoli, G., J. Krietsch, A. Weick, S. Steinfelder, F. Facciotti, P. Gruarin, A. Bianco, B. Steckel, M. Moro, M. Crosti, et al. 2013. Human CD1c+ dendritic cells secrete high levels of IL-12 and potently prime cytotoxic T-cell responses. Blood 122: 932-942.
53. Sallusto, F., J. Geginat, and A. Lanzavecchia. 2004. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu. Rev. Immunol. 22: 745-763.
54. Song, K., R. L. Rabin, B. J. Hill, S. C. De Rosa, S. P. Perfetto, H. H. Zhang, J. F. Foley, J. S. Reiner, J. Liu, J. J. Mattapallil, et al. 2005. Characterization of subsets of CD4+ memory T cells reveals early branched pathways of T cell differentiation in humans. Proc. Natl. Acad. Sci. USA 102: 7916-7921.
55. Gattinoni, L ., E. Lugli, Y. Ji, Z. Pos, C. M. Paulos, M. F. Quigley, J. R. Almeida, E. Gostick, Z. Yu, C. Carpenito, et al. 2011. A human memory T cell subset with stem cell-like properties. Nat. Med. 17: 1290- 1297.
56. Zhou, L., J. E. Lopes, M. M. Chong, I. I. Ivanov, R.Min, G. D. Victora, Y. Shen, J. Du, Y. P. Rubtsov, A. Y. Rudensky, et al. 2008. TGF-beta-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature 453: 236-240.
57. Ghoreschi, K., A. Laurence, X. P. Yang, C. M. Tato, M. J. McGeachy, J. E. Konkel, H. L. Ramos, L. Wei, T. S. Davidson, N. Bouladoux, et al. 2010. Generation of pathogenic T(H)17 cells in the absence of TGF-b signalling. Nature 467: 967-971.
58. Lee, Y., A. Awasthi, N. Yosef, F. J. Quintana, S . Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13: 991-999.
59. Rivino, L., M. Messi, D. Jarrossay, A. Lanzavecchia, F. Sallusto, and J. Geginat. 2004. Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells. J. Exp. Med. 200: 725-735.
60. Liu, H., and C. Rohowsky-Kochan. 2008. Regulation of IL-17 in human CCR6+ effector memory T cells. J. Immunol. 180: 7948-7957.
61. Wurster, A. L., V. L. Rodgers, A. R. Satoskar, M. J. Whitters, D. A. Young, M. Collins, and M. J. Grusby. 2002. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 196: 969-977.
62. Suto, A., A. L. Wurster, S. L. Reiner, and M. J. Grusby. 2006. IL-21 inhibits IFNgamma production in developing Th1 cells through the repression of Eomesodermin expression. J. Immunol. 177: 3721-3727.
63. Wan, C. K., J. Oh, P. Li, E. E. West, E. A. Wong, A. B. Andraski, R. Spolski, Z. X. Yu, J. He, B. L. Kelsall, and W. J. Leonard. 2013. The cytokines IL-21 and GM-CSF have opposing regulatory roles in the apoptosis of conventional dendritic cells. Immunity 38: 514-527.
64. Strengell, M., S. Matikainen, J. Sirén, A. Lehtonen, D. Foster, I. Julkunen, and T. Sareneva. 2003. IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. J. Immunol. 170: 5464-5469.
65. Mon teleone, G., I. Monteleone, D. Fina, P. Vavassori, G. Del Vecchio Blanco, R. Caruso, R. Tersigni, L. Alessandroni, L. Biancone, G. C. Naccari, et al. 2005. Interleukin-21 enhances T-helper cell type I signa ling and interferon-gamma production in Crohn's disease. Gastroenterology 128: 687-694.
66. Hinrichs, C. S., R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo. 2008. IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy. Blood 111: 5326-5333.
67. Annunziat o, F., and S. Romagnani. 2009. Do studies in humans better depict Th17 cells? Blood 114: 2213-2219.
68. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649.
69. Kullberg, M. C., D. Jankovic, C. G. Feng, S. Hue, P. L. Gorelick, B. S. McKenzie, D. J. Cua, F. Powrie, A. W. Cheever, K. J. Maloy, and A. Sher. 2006. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 203: 2485-2494.
70. McKenzie, B. S., R. A. Kastelein, and D. J. Cua. 2006. Understanding the IL-23-IL-17 immune pathway. Trends Immunol. 27: 17-23.
71. Marijnissen, R. J., D. M. Roeleveld, D. Youn g, C. Nickerson-Nutter, S. Abdollahi-Roodsaz, S. Garcia de Aquino, F. A. van de Loo, A. B. van Spriel, A. M. Boots, W. B. van den Berg, and M. I. Koenders. 2014. IL-21R-deficiency increases the initial TLR2 respo nse but protects against joint pathology by reducing Th1/17 cells during SCW-arthritis. Arthritis Rheumatol. 66: 886-95.